Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

New compounds may soon be tested to treat excessive hair growth in women.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Finasteride helps induce ovulation in nonresponder PCOS women.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Oral contraceptives help mild hirsutism, while flutamide and spironolactone help severe cases.

Neurosteroids like allopregnanolone help control cell death and growth in the developing fetal brain.

Oral contraceptives are effective for treating hyperandrogenism, while ovarian electrocautery is better for women with infertility.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Prostaglandin F2α may help treat hair loss by promoting hair growth.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Minoxidil is the only drug proven to improve female hair loss, and dextroamphetamine sulfate may be a new treatment for certain types of hair loss.

Female guinea pigs exposed to less allopregnanolone before birth showed more anxiety-like behavior.

Topical prostaglandin analogs may help with hair growth but more research is needed.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Sex hormones influence immune responses and may help treat diseases.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.